Barrett Evans

Phytanix Bio, a preclinical stage pharmaceutical company, has released an updated investor deck. The presentation showcases a business strategy aimed at developing new cannabinoid-based pharmaceuticals. The company, which has ties to historical pharmaceutical developments in the cannabis industry,...

Chain Bridge I (NASDAQ:CBRG) announced on Monday the acquisition of Phytanix Bio, a pharmaceutical company specializing in the development of therapeutics based on cannabinoid and cannabinoid-like molecules. The transaction, valued at $58 million, also includes the assumption of preferred stock and...

Bloomios, Inc. (OTCQB: BLMS), has acquired Infusionz, a wholly-owned subsidiary of Upexi Inc. (NASDAQ: UPXI). Moving forward, Bloomios will manufacture products retained by Upexi and Upexi has provided significant financing to enable this transaction. The acquisition includes Infusionz's...

Bloomios, Inc. (OTCQB: BLMS) has been selected as the exclusive CBD product manufacturer for DRYWORLD (OTC: IBGR), a maker of purpose-driven sports products designed to give athletes a performance edge. DRYWORLD engaged Bloomios to co-develop and produce the company's branded, high-...